Bastide Kristell, Guilly Marie-Noëlle, Bernaudin Jean-François, Joubert Christophe, Lectard Bruno, Levalois Céline, Malfoy Bernard, Chevillard Sylvie
CEA, DSV, IRCM, SREIT, Laboratoire de Cancérologie Expérimentale, BP6, Fontenay-aux-Roses Cedex F-92265, France.
Lung Cancer. 2009 Mar;63(3):348-53. doi: 10.1016/j.lungcan.2008.06.007. Epub 2008 Jul 25.
Inhalation of radon is closely associated with an increased risk of lung cancers. While the involvement of Ink4a in lung tumor development has been widely described, the tumor suppressor gene has not been studied in radon-induced lung tumors. In this study, loss of heterozygosity (LOH) analysis of the Cdkn2a locus, common to the Ink4a and Arf genes, was performed on 33 radon-induced rat lung tumors and showed a DNA loss in 50% of cases. The analysis of p16(Ink4a) protein expression by immunohistochemistry revealed that 50% of the tumors were negative for this protein. Looking for the origin of this lack of expression, we observed a low frequency of homozygous deletion (6%), a lack of mutation, an absence of correlation between promoter methylation and Ink4a mRNA expression and no correlation between LOH and protein expression. However, a tendency for an inverse correlation between p16(Ink4a) and pRb protein expression was observed. The expressions of p19Arf, Mmd2 and Mdm4 were not deregulated and only 14% of the tumors were mutated for Tp53. These results indicated that Ink4a/Cdk4/Rb1 pathway deregulation, more than Arf/Mdm2/Tp53 pathway, has a major role in the development of these tumors through p16(Ink4a) deregulation. However, all known mechanisms of inactivation of the pathway do not play a recurrent role in these tumors and the actual origin of the lack of p16(Ink4a) protein expression remains to be established.
吸入氡与肺癌风险增加密切相关。虽然Ink4a在肺肿瘤发生中的作用已被广泛描述,但该肿瘤抑制基因在氡诱导的肺肿瘤中尚未得到研究。在本研究中,对33例氡诱导的大鼠肺肿瘤进行了Ink4a和Arf基因共有的Cdkn2a位点杂合性缺失(LOH)分析,结果显示50%的病例存在DNA缺失。通过免疫组织化学分析p16(Ink4a)蛋白表达,发现50%的肿瘤该蛋白呈阴性。为探寻这种表达缺失的原因,我们观察到纯合缺失频率较低(6%),无突变情况,启动子甲基化与Ink4a mRNA表达之间无相关性,LOH与蛋白表达之间也无相关性。然而,观察到p16(Ink4a)与pRb蛋白表达之间存在负相关趋势。p19Arf、Mmd2和Mdm4的表达未失调,仅14%的肿瘤Tp53发生突变。这些结果表明,Ink4a/Cdk4/Rb1通路失调而非Arf/Mdm2/Tp53通路,通过p16(Ink4a)失调在这些肿瘤的发生中起主要作用。然而,该通路所有已知的失活机制在这些肿瘤中并非反复发挥作用,p16(Ink4a)蛋白表达缺失的实际原因仍有待确定。